Intensive care admission of cancer patients: a comparative analysis

Cancer Medicine

Monique M. E. M. Bos¹  Ilona W. M. Verburg⁴  Ineke Dumaij¹  Jacqueline Stouthard²  Johannes W. R. Nortier⁵  Dick Richel³  Eric P.A. van der Zwan⁴  Nicolette F. de Keizer⁴ 

[1] Department of Medicine, Reinier de Graaf Hospital, Delft, The Netherlands;Department of Medical Oncology, Antoni van Leeuwenhoek Hospital, Dutch Cancer Institute, Amsterdam, The Netherlands;Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands

关键词: Age differences;    cancer;    gender differences;    intensive care;    survival;   

DOI  :  10.1002/cam4.430

来源: Wiley

【 摘 要 】

Abstract

The aim of this study was to obtain insight into which proportion of cancer patients is admitted to an Intensive Care Unit (ICU) and how their survival, demographic, and clinical characteristics relate to cancer patients not admitted to the ICU. Data from patients registered with cancer between 2006 and 2011 in four hospitals in the Netherlands were linked to the Dutch National Intensive Care Evaluation registry. About 36,860 patients with cancer were identified, of whom 2,374 (6.4%) were admitted to the ICU. Fifty-six percent of ICU admissions were after surgery, whereas 44% were for medical reasons. The risk for ICU admission was highest among cancer patients treated with surgery either alone or combined with chemotherapy and/or radiation therapy. Only 80 of 1,073 medical ICU admissions (3.3%) were for cancer-specific reasons. Although more women (54.0%) than men were registered with cancer, the proportion of male cancer patients admitted to an ICU was much higher (9.3 vs. 4.0%, P < 0.001). Five-year survival of cancer patients admitted to the ICU was substantial (41%) although median survival was much lower (1,104 days) than in patients not admitted to the ICU (median survival time not reached, P < 0.001). These results show that one out of 16 cancer patients was admitted to an ICU and that ICU support for this group should not be considered futile.

【 授权许可】

CC BY   
© 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.